254 related articles for article (PubMed ID: 24901591)
1. Malignant melanoma presenting as a nonhealing heel ulceration.
Fussell JN; Troutman DL; Hossler E; Agarwal S
J Am Podiatr Med Assoc; 2014 May; 104(3):295-7. PubMed ID: 24901591
[TBL] [Abstract][Full Text] [Related]
2. The importance of wound biopsy in the accurate diagnosis of acral malignant melanoma presenting as a foot ulcer.
Yin NC; Miteva M; Covington DS; Romanelli P; Stojadinovic O
Int J Low Extrem Wounds; 2013 Dec; 12(4):289-92. PubMed ID: 24323391
[TBL] [Abstract][Full Text] [Related]
3. [Sentinel lymph node biopsy in patients with cutaneous melanoma].
Jahkola T; Virolainen S; Leppänen E; Suominen S; Hernberg M; Hahka-Kemppinen M; Saksela O
Duodecim; 2002; 118(22):2289-94. PubMed ID: 12523105
[No Abstract] [Full Text] [Related]
4. Sentinel lymph node biopsy for the T1 (thin) melanoma: is it necessary?
Nahabedian MY; Tufaro AP; Manson PN
Ann Plast Surg; 2003 Jun; 50(6):601-6. PubMed ID: 12783009
[TBL] [Abstract][Full Text] [Related]
5. [Malignant melanoma masquerading as a neurotrophic ulcer].
Schöttler L; Körber A; Denisjuk N; Freise J; Dissemond J
Med Klin (Munich); 2009 Sep; 104(9):723-6. PubMed ID: 19779677
[TBL] [Abstract][Full Text] [Related]
6. "The malignant wart": a review of primary nodular melanoma of the foot and report of two cases.
Schade VL; Roukis TS; Homann JF; Brown T
J Foot Ankle Surg; 2010; 49(3):263-73. PubMed ID: 20605563
[TBL] [Abstract][Full Text] [Related]
7. Sentinel lymph node excision and positron emission tomography and computed tomography in the initial stage of malignant melanoma.
Hafner J
Dermatol Surg; 2010 Dec; 36(12):2082-3. PubMed ID: 21126282
[No Abstract] [Full Text] [Related]
8. Ulceration as a predictive marker for response to adjuvant interferon therapy in melanoma.
McMasters KM; Edwards MJ; Ross MI; Reintgen DS; Martin RC; Urist MM; Noyes RD; Sussman JJ; Stromberg AJ; Scoggins CR
Ann Surg; 2010 Sep; 252(3):460-5; discussion 465-6. PubMed ID: 20739846
[TBL] [Abstract][Full Text] [Related]
9. [Important prognostic significance of a sentinel-node biopsy in patients with malignant melanoma].
Keijzer R; Bril H; van der Loo EM; de Graaf PW
Ned Tijdschr Geneeskd; 2004 May; 148(18):884-8. PubMed ID: 15152391
[TBL] [Abstract][Full Text] [Related]
10. Current concepts in cutaneous melanoma: malignant melanoma.
Doben AR; MacGillivray DC
Surg Clin North Am; 2009 Jun; 89(3):713-25. PubMed ID: 19465207
[TBL] [Abstract][Full Text] [Related]
11. Atypical Spitzoid neoplasms: a review of potential markers of biological behavior including sentinel node biopsy.
McCormack CJ; Conyers RK; Scolyer RA; Kirkwood J; Speakman D; Wong N; Kelly JW; Henderson MA
Melanoma Res; 2014 Oct; 24(5):437-47. PubMed ID: 24892957
[TBL] [Abstract][Full Text] [Related]
12. Not all lesions with a verrucous surface are seborrheic keratoses.
Longo C; Moscarella E; Piana S; Lallas A; Carrera C; Pellacani G; Zalaudek I; Argenziano G
J Am Acad Dermatol; 2014 Jun; 70(6):e121-3. PubMed ID: 24831328
[No Abstract] [Full Text] [Related]
13. Acral malignant melanoma and striated palmoplantar keratoderma (Brunauer-Fohs-Siemens syndrome): a fortuitous association?
Rubegni P; Poggiali S; Cuccia A; Biagioli M; Fimiani M
Dermatol Surg; 2004 Dec; 30(12 Pt 2):1539-42. PubMed ID: 15606835
[TBL] [Abstract][Full Text] [Related]
14. Management of early-stage cutaneous melanoma.
Aloia TA; Gershenwald JE
Curr Probl Surg; 2005 Jul; 42(7):460-534. PubMed ID: 16099230
[No Abstract] [Full Text] [Related]
15. Pathological assessment of tumor biopsy specimen and surgical sentinel lymph node dissection in patients with melanoma.
Nodiţi G; Nica CC; Petrescu HP; Ivan C; Crăiniceanu ZP; Bratu T; Dema A
Rom J Morphol Embryol; 2014; 55(3):915-8. PubMed ID: 25329120
[TBL] [Abstract][Full Text] [Related]
16. Principles of surgical treatment of malignant melanoma.
Kimbrough CW; McMasters KM; Davis EG
Surg Clin North Am; 2014 Oct; 94(5):973-88, vii. PubMed ID: 25245962
[TBL] [Abstract][Full Text] [Related]
17. Amelanotic acral lentiginous melanoma mimicking diabetic ulcer: a challenge to diagnose and treat.
Kaneko T; Korekawa A; Akasaka E; Nakano H; Sawamura D
Eur J Dermatol; 2016; 26(1):107-8. PubMed ID: 26679765
[No Abstract] [Full Text] [Related]
18. Outcomes and prognostic factors in nodular melanomas.
Egger ME; Dunki-Jacobs EM; Callender GG; Quillo AR; Scoggins CR; Martin RC; Stromberg AJ; McMasters KM
Surgery; 2012 Oct; 152(4):652-9; discussion 659-60. PubMed ID: 22925134
[TBL] [Abstract][Full Text] [Related]
19. Sentinel lymph node biopsy status is a key parameter to stratify the prognostic heterogeneity of malignant melanoma in high-risk tumors >4.0 mm.
Göppner D; Ulrich J; Pokrywka A; Peters B; Gollnick H; Leverkus M
Dermatology; 2011 Feb; 222(1):59-66. PubMed ID: 21196701
[TBL] [Abstract][Full Text] [Related]
20. Breslow thickness, clark index and ulceration are associated with sentinel lymph node metastasis in melanoma patients: a cohort analysis of 612 patients.
Munsch C; Lauwers-Cances V; Lamant L; Gentil C; Rochaix P; Garrido I; Lopez R; Chevreau C; Paul C; Meyer N
Dermatology; 2014; 229(3):183-9. PubMed ID: 25171688
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
